March 26, 2020
During the current COVID-19 crisis patient safety remains a priority for all our existing research patients. NICTN has consequently taken the decision to suspend recruitment to the majority of clinical trials and other research studies until further notice. This decision will remain under constant review.
Anyone with concerns about their treatment options should discuss this with their own doctor.